Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

This Analyst Thinks M&A Involving Q2 Holdings Customers Key Variable To Outlook

By Anusuya Lahiri
September 28, 1:12 PM
Stephens analyst Charles Nabhan reiterated an Equal-Weight (Volatile) on Q2 Holdings, Inc (NYSE:QTWO) and a $55 price target. With several proposed transactions still…

QTWO

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Movers
  • Price Target
  • Reiteration
  • Trading Ideas

7 Biogen Analysts On Alzheimer’s Drug Success As Stock Skyrockets 37%

By Priya Nigam
September 28, 12:10 PM
Shares of Biogen Inc (NASDAQ: BIIB) were flying on Wednesday, after the biopharma company said its experimental Alzheimer’s drug with Japanese partner Eisai showed promising results. RBC Capital Markets On Biogen

BIIB

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

IMAX’s High Profile Film Releases In Q4 & 2023 Make This Analyst Remain Bullish

By Anusuya Lahiri
September 26, 2:52 PM
Rosenblatt analyst Steve Frankel reiterated a Buy and $25 price target on IMAX Corp (NYSE:IMAX). The analyst reaffirmed his bullish view citing high-profile…

IMAX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Initiation
  • News
  • Price Target
  • Reiteration
  • Tech

Smartsheet Analyst Concerns Are Priced In; Remains Sidelined Given Crowded Competition

By Anusuya Lahiri
September 26, 2:09 PM
RBC Capital analyst Rishi Jaluria kept his Sector Perform rating and $32 price target on Smartsheet Inc (NYSE:SMAR) after attending its Engage 2022…

SMAR

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Rosenblatt Sees Micron’s 2023 Setup As Positive; Expects Stock Price To Double

By Anusuya Lahiri
September 26, 2:01 PM
Micron Technology, Inc (NASDAQ: MU) reports August quarter earnings on September 29, after the market close.

MU

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks
  • Price Target
  • Reiteration

Inventiva’s NASH Pact In China Represents ‘Financially Prudent Pathway,’ Says This Analyst

By Vandana Singh
September 26, 1:37 PM
Last week, Inventiva (NASDAQ:IVA) announced a licensing and collaboration agreement with Sino Biopharm’s subsidiary Chia Tai-Tianqing Pharmaceutical Group (CTTQ) to…

IVA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Here’s Why Wells Fargo Continues To Recommend Zscaler As A ‘Top Pick’

By Anusuya Lahiri
September 26, 1:03 PM
Wells Fargo analyst Andrew Nowinski recently had the opportunity to travel with Zscaler, Inc (NASDAQ: ZS) management and came away with a better understanding of the importance of improving channel dynamics. 

ACN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • News
  • Reiteration
  • Social Media
  • Tech
  • Top Stories

Meta, Snap, TikTok, Pinterest, Twitter All Saw Engagement Improve In Q3 — But Analyst Says 1 Platform Stands Out

By Shanthi Rexaline
September 26, 7:13 AM
Engagement trends for social media platforms improved sequentially in the third quarter, KeyBanc Capital Markets said, citing its quarterly consumer survey.

META

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

F5 Could More Than Double As Solid Demand Trends Continue & Supply Constrains Start To Ease, Needham Says

By Anusuya Lahiri
September 23, 3:24 PM
Needham analyst Alex Henderson reiterated a Buy and $303 price target on F5, Inc (NASDAQ:FFIV). F5 was careful not to update conditions post…

CSCO

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • News
  • Penny Stocks
  • Price Target
  • Reiteration
  • Travel

This Analyst Sees ‘Multiple Catalysts’ To Drive Revenue Growth For Yatra

By Shivani Kumaresan
September 23, 3:07 PM
H.C. Wainwright analyst Scott Buck reiterated a Buy rating on the shares of Yatra Online Inc (NASDAQ:YTRA) with a price target of $4.…

YTRA

Posts pagination

Previous 1 … 364 365 366 … 399 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service